We are live on ! Find out more
WST icon

West Pharmaceutical

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4%91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
51
ExodusPoint Capital Management
New York
$24.8M +$22.2M +161,322 +1,165%
Kayne Anderson Rudnick Investment Management
52
Kayne Anderson Rudnick Investment Management
California
$24.8M +$1.7M +12,380 +8%
First Trust Advisors
53
First Trust Advisors
Illinois
$22M +$14.3M +103,619 +201%
RSCM
54
Rock Springs Capital Management
Maryland
$21.6M +$2.07M +15,000 +11%
AAMU
55
Amundi Asset Management US
Massachusetts
$21.6M +$648K +4,706 +3%
Envestnet Asset Management
56
Envestnet Asset Management
Illinois
$21.2M +$410K +2,981 +2%
AIG
57
American International Group
New York
$20.1M -$289K -2,099 -1%
Los Angeles Capital Management
58
Los Angeles Capital Management
California
$20.1M +$10.8M +78,148 +123%
Loomis, Sayles & Company
59
Loomis, Sayles & Company
Massachusetts
$19.9M +$1.75M +12,714 +10%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$19.7M -$413K -3,000 -2%
Arrowstreet Capital
61
Arrowstreet Capital
Massachusetts
$19.7M +$3.64M +26,429 +24%
Swiss National Bank
62
Swiss National Bank
Switzerland
$19.6M +$41.3K +300 +0.2%
SEI Investments
63
SEI Investments
Pennsylvania
$19.4M +$2.37M +17,214 +14%
William Blair & Company
64
William Blair & Company
Illinois
$19.2M -$35K -254 -0.2%
Deutsche Bank
65
Deutsche Bank
Germany
$19.1M +$9.92M +72,047 +115%
Citadel Advisors
66
Citadel Advisors
Florida
$18.2M +$9.18M +66,639 +108%
Legal & General Group
67
Legal & General Group
United Kingdom
$18.1M +$392K +2,844 +2%
SCP
68
Sandhill Capital Partners
New York
$18M -$1.19M -8,642 -6%
ProShare Advisors
69
ProShare Advisors
Maryland
$17.5M +$591K +4,289 +4%
TD Asset Management
70
TD Asset Management
Ontario, Canada
$17.1M +$322K +2,340 +2%
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$16.7M +$162K +1,178 +1%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$15.4M -$1.41M -10,250 -9%
UBS AM
73
UBS AM
Illinois
$15.3M +$585K +4,248 +4%
Squarepoint
74
Squarepoint
New York
$15.2M +$9.26M +67,270 +170%
State Farm Mutual Automobile Insurance
75
State Farm Mutual Automobile Insurance
Illinois
$15.2M

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.